12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Sat, 24 May 2025 20:06:09 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} [5] => Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=UCEn98400d8u4qOMSR42Z%2BFXQN8j6%2F9n03uYbredbG3b4U5cpN3P0t2IMijtHGIEFcQL9wiL151%2B48zDye1%2Bwmu34%2BX5PHhlXi2cu4RD8LDka01rYZyTjDt%2F1cZrxsVIgKQ%3D"}],"group":"cf-nel","max_age":604800} [6] => Server: cloudflare [7] => Vary: Accept-Encoding [8] => X-Powered-By: PHP/7.4.33 [9] => Cache-Control: no-cache, private [10] => Cf-Ray: 944f69736fcd469a-KUL [11] => X-Frame-Options: SAMEORIGIN [12] => X-Xss-Protection: 1; mode=block [13] => X-Content-Type-Options: nosniff [14] => Referrer-Policy: no-referrer-when-downgrade [15] => Cf-Cache-Status: DYNAMIC [16] => Set-Cookie: UpalLiveSession=eyJpdiI6IitCZ2JvNWRQVzJ2ZWpnXC8xMkplTWRnPT0iLCJ2YWx1ZSI6IjExaFQrTnNoUWlYVFlzK3JOMXdtYTNEYXdwVXlHQlpkclU4bWJjVU9ieGNiVDZITmVKNStteWRvVk9aMDhnK2xOOVk1MkZhTklqQ2Z5UVNKM2ZIajJBPT0iLCJtYWMiOiI1Mjk4NzUxMDc3MjdhMDIzY2I1MDI5YWE2ZmM1YTQxMDZhNWJiYTVlNTJjZWQ0NGE0ZjZlMGM1OWRmOGJkNWY1In0%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Tue, 23 May 2028 19:43:23 GMT [17] => alt-svc: h3=":443"; ma=86400 [18] => server-timing: cfL4;desc="?proto=TCP&rtt=2762&min_rtt=986&rtt_var=3797&sent=4&recv=6&lost=0&retrans=0&sent_bytes=3000&recv_bytes=756&delivery_rate=2937119&cwnd=252&unsent_bytes=0&cid=8267aceaee048794&ts=31&x=0" ) 789

军事科学院军事医学研究院的科研团队研制的新冠疫苗至周一通过临床研究注册审评，获批启动展开临床试验。

自新冠肺炎疫情爆发以来，多个国家都致力研发疫苗，该科究团队一直展开疫苗研制的应急科研攻关。

科研团队由中国工程院院士、军事科学院军事医学研究院研究员陈薇领衔。她近日受访时指，按照国际规范及国内法规，疫苗已做了安全、有效、质量可控、可大规模生产的前期准备工作。

据了解，该团队自1月26日抵达武汉以来，就与地方企业在伊波拉疫苗成功研发的经验基础上，开展重组新冠病毒疫苗的药学、药效学、药理毒理等研究，快速完成新冠疫苗设计、重组毒种构建和GMP条件下生产制备，以及第三方疫苗安全性、有效性评价和质量覆核。

---

// // // //